How similar is biosimilar? A comparison of infliximab therapeutics in regard to charge variant profile and antigen binding affinity
B Beyer, N Walch, A Jungbauer… - Biotechnology …, 2019 - Wiley Online Library
Biosimilars are increasing in economic importance. Just how similar a biosimilar needs to be
to gain market approval is currently still decided on a per case basis. The authors try to shed …
to gain market approval is currently still decided on a per case basis. The authors try to shed …
[PDF][PDF] How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity
B Beyer, N Walch, A Jungbauer, N Lingg - 2018 - researchgate.net
Biosimilars are increasing in economic importance. Just how similar a biosimilar needs to be
to gain market approval is currently still decided on a per case basis. The authors try to shed …
to gain market approval is currently still decided on a per case basis. The authors try to shed …
How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity
B Beyer, N Walch, A Jungbauer… - Biotechnology …, 2019 - pubmed.ncbi.nlm.nih.gov
Biosimilars are increasing in economic importance. Just how similar a biosimilar needs to be
to gain market approval is currently still decided on a per case basis. The authors try to shed …
to gain market approval is currently still decided on a per case basis. The authors try to shed …
How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity
B Beyer, N Walch, A Jungbauer… - Biotechnology …, 2019 - Wiley Online Library
Biosimilars are increasing in economic importance. Just how similar a biosimilar needs to be
to gain market approval is currently still decided on a per case basis. The authors try to shed …
to gain market approval is currently still decided on a per case basis. The authors try to shed …
How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity.
B Beyer, N Walch, A Jungbauer, N Lingg - Biotechnology Journal, 2018 - europepmc.org
Biosimilars are increasing in economic importance. Just how similar a biosimilar needs to be
to gain market approval is currently still decided on a per case basis. The authors try to shed …
to gain market approval is currently still decided on a per case basis. The authors try to shed …